| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
138,800,000 |
| Market
Cap: |
1.45(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$4.7 - $15 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Maravai is a holding company. Through its subsidiaries, Co. operates as a life sciences company that provides products to enable the development of drug, therapies, diagnostics, vaccines, and support research on human diseases. Co. operates in two segments: Nucleic Acid Production, which includes messenger ribonucleic acid, long and short oligonucleotides, its CleanCap® capping technology and oligonucleotide building blocks; and Biologics Safety Testing, which sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Gtcr Partners Xi/b Lp |
Director |
– • • |
2021-09-09 |
4 |
D |
$50.00 |
$146,572,050 |
I/I |
(2,931,441) |
21,681,033 |
|
- |
|
| Dolan Christine |
See Remarks |
• – – |
2021-04-30 |
4 |
A |
$22.95 |
$21,022 |
D/D |
916 |
916 |
|
- |
|
| Oreshack Kurt |
General Counsel |
• – – |
2021-04-30 |
4 |
A |
$22.95 |
$11,360 |
D/D |
495 |
7,995 |
|
- |
|
| Neel Brian |
See Remarks |
• – – |
2021-04-30 |
4 |
A |
$22.95 |
$6,564 |
D/D |
286 |
286 |
|
- |
|
| Herde Kevin |
Chief Financial Officer |
• – – |
2021-04-30 |
4 |
A |
$22.95 |
$11,406 |
D/D |
497 |
497 |
|
- |
|
| Gtcr Partners Xi/b Lp |
Director |
– • • |
2021-04-08 |
4 |
D |
$0.00 |
$0 |
I/I |
(2,304,256) |
143,308,170 |
|
- |
|
| Gtcr Partners Xi/b Lp |
Director |
– • • |
2021-04-08 |
4 |
D |
$31.25 |
$12,367,000 |
I/I |
(395,744) |
24,612,474 |
|
- |
|
| Gtcr Partners Xi/b Lp |
Director |
– • • |
2021-04-07 |
4 |
D |
$0.00 |
$0 |
I/I |
(15,361,703) |
145,612,426 |
|
- |
|
| Gtcr Partners Xi/b Lp |
Director |
– • • |
2021-04-07 |
4 |
D |
$31.25 |
$82,446,781 |
I/I |
(2,638,297) |
25,008,218 |
|
- |
|
| Hull Carl |
Chief Executive Officer |
• • – |
2020-11-25 |
4 |
B |
$26.94 |
$942,900 |
I/I |
35,000 |
35,000 |
2.66 |
23% |
|
| Gtcr Partners Xi/b Lp |
Director |
– • • |
2020-11-24 |
4 |
D |
$0.00 |
$0 |
I/I |
(7,680,852) |
160,974,129 |
|
- |
|
| Gtcr Partners Xi/b Lp |
Director |
– • • |
2020-11-24 |
4 |
D |
$25.52 |
$33,658,061 |
I/I |
(1,319,148) |
27,646,515 |
|
- |
|
| Gray Susannah |
Director |
– • – |
2020-11-24 |
4 |
B |
$27.00 |
$540,000 |
D/D |
20,000 |
31,852 |
2.39 |
23% |
|
| Prahalad Murali |
Director |
– • – |
2020-11-24 |
4 |
B |
$27.00 |
$486,000 |
D/D |
18,000 |
29,852 |
2.39 |
23% |
|
| Lucier Gregory T |
Director |
– • – |
2020-11-24 |
4 |
B |
$27.00 |
$405,000 |
D/D |
15,000 |
26,852 |
2.39 |
23% |
|
| Oreshack Kurt |
General Counsel |
• – – |
2020-11-24 |
4 |
B |
$27.00 |
$202,500 |
D/D |
7,500 |
7,500 |
2.74 |
23% |
|
| Hopfield Jessica |
Director |
– • – |
2020-11-24 |
4 |
B |
$27.00 |
$1,350,000 |
D/D |
50,000 |
61,852 |
2.39 |
23% |
|
| Sellers Lisa |
See Remarks |
• – – |
2020-11-24 |
4 |
B |
$27.00 |
$509,976 |
D/D |
18,888 |
18,888 |
2.74 |
23% |
|
| Hance Robert B |
Director |
– • – |
2020-11-24 |
4 |
B |
$27.00 |
$270,000 |
D/D |
10,000 |
21,852 |
2.39 |
23% |
|
| Gray Susannah |
Director |
– • – |
2020-11-19 |
4 |
A |
$0.00 |
$0 |
D/D |
11,852 |
11,852 |
|
- |
|
| Ashkenazi Anat |
Director |
– • – |
2020-11-19 |
4 |
A |
$0.00 |
$0 |
D/D |
11,852 |
11,852 |
|
- |
|
| Prahalad Murali |
Director |
– • – |
2020-11-19 |
4 |
A |
$0.00 |
$0 |
D/D |
11,852 |
11,852 |
|
- |
|
| Lucier Gregory T |
Director |
– • – |
2020-11-19 |
4 |
A |
$0.00 |
$0 |
D/D |
11,852 |
11,852 |
|
- |
|
| Hance Robert B |
Director |
– • – |
2020-11-19 |
4 |
A |
$0.00 |
$0 |
D/D |
11,852 |
11,852 |
|
- |
|
| Hopfield Jessica |
Director |
– • – |
2020-11-19 |
4 |
A |
$0.00 |
$0 |
D/D |
11,852 |
11,852 |
|
- |
|
102 Records found
|
|
Page 4 of 5 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.60 (6.09%) 
